Xeris Biopharma Holdings Inc (XERS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access XERS Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Xeris Biopharma Holdings Inc.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent121.75
Cash, Cash Equivalents Other121.75
Cash & Short-term Investments242.00
Accounts receivable58.11
Inventories80.93
Prepaid Expense, Current AS13.98
Total Current Assets274.76
Equipment/Property/Plant Net13.67
Goodwill net22.86
Intangible Assets82.66
Other Assets, Noncurrent17.96
Operating Lease Right Of Use Asset21.95
Total Assets411.91
Liabilities
Accounts Payable, Current AC9.34
Accrued Liabilities, Current AC39.71
Long-term Debt, Current Maturities LO63.78
Other Liabilities, Current0.00
Total Current Liabilities189.57
Long-term debt252.59
Total Long-term Debt252.59
Other liabilities, Noncurrent56.22
Operating Lease Liability Current6.27
Accruedreturnsreserve18.72
Operating Lease Liability Noncurrent31.06
Total Liabilities421.64
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock690.43
Retained Earnings / Accumulated Deficit-700.17
Accumulated Other Comprehensive Income-0.01
Other Equity-0.01
Common Stockholder's Equity-9.73
Total Stockholder's Equity-9.73
Liabilities & Stockholder's Equity411.91
4 historic quarters locked

Sign in to unlock the full Xeris Biopharma Holdings Inc balance sheet history.

About Xeris Biopharma Holdings Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001867096-26-000065

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.